1. Home
  2. GKOS vs REZI Comparison

GKOS vs REZI Comparison

Compare GKOS & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • REZI
  • Stock Information
  • Founded
  • GKOS 1998
  • REZI 2018
  • Country
  • GKOS United States
  • REZI United States
  • Employees
  • GKOS N/A
  • REZI N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • REZI Wholesale Distributors
  • Sector
  • GKOS Health Care
  • REZI Industrials
  • Exchange
  • GKOS Nasdaq
  • REZI Nasdaq
  • Market Cap
  • GKOS 5.4B
  • REZI 6.1B
  • IPO Year
  • GKOS 2015
  • REZI N/A
  • Fundamental
  • Price
  • GKOS $87.64
  • REZI $40.73
  • Analyst Decision
  • GKOS Strong Buy
  • REZI Buy
  • Analyst Count
  • GKOS 13
  • REZI 3
  • Target Price
  • GKOS $120.38
  • REZI $34.67
  • AVG Volume (30 Days)
  • GKOS 718.5K
  • REZI 1.4M
  • Earning Date
  • GKOS 10-29-2025
  • REZI 11-05-2025
  • Dividend Yield
  • GKOS N/A
  • REZI N/A
  • EPS Growth
  • GKOS N/A
  • REZI N/A
  • EPS
  • GKOS N/A
  • REZI N/A
  • Revenue
  • GKOS $432,953,000.00
  • REZI $7,399,000,000.00
  • Revenue This Year
  • GKOS $28.90
  • REZI $13.22
  • Revenue Next Year
  • GKOS $25.57
  • REZI $3.40
  • P/E Ratio
  • GKOS N/A
  • REZI N/A
  • Revenue Growth
  • GKOS 26.70
  • REZI 20.00
  • 52 Week Low
  • GKOS $77.10
  • REZI $14.18
  • 52 Week High
  • GKOS $163.71
  • REZI $43.96
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.74
  • REZI 54.00
  • Support Level
  • GKOS $82.19
  • REZI $39.36
  • Resistance Level
  • GKOS $86.74
  • REZI $42.31
  • Average True Range (ATR)
  • GKOS 3.27
  • REZI 1.27
  • MACD
  • GKOS 0.56
  • REZI -0.57
  • Stochastic Oscillator
  • GKOS 82.87
  • REZI 29.78

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: